ReviewCureus2026
Association Between Type 2 Diabetes Mellitus and Sepsis Outcomes: A Systematic Review and Meta-Analysis.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a major cause of morbidity and mortality worldwide. Type 2 diabetes mellitus (T2DM) is common among adults with infection and has been proposed as a potential modifier of sepsis outcomes. This systematic review and meta-analysis aimed to evaluate the association between pre-existing T2DM and mortality among adults with sepsis. This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. PubMed, Cochrane CENTRAL, and Google Scholar databases were systematically searched from inception to April 23, 2026. Observational studies comparing outcomes in adult patients with sepsis with and without T2DM were eligible. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model. A total of 651 records were identified. Seven studies were included in the qualitative synthesis, and three in the primary quantitative meta-analysis. The pooled analysis showed no statistically significant association between T2DM and sepsis mortality (OR = 0.99; 95% CI = 0.82-1.20). However, substantial heterogeneity was observed across studies (I² = 98.4%). Sensitivity and exploratory analyses yielded similar findings. Narrative evidence suggested that glycemic status, diabetes-related complications, and acute renal dysfunction may be more important determinants of outcomes than the diagnosis of T2DM alone. The current evidence did not demonstrate a statistically significant association between pre-existing T2DM and mortality among adults with sepsis. However, these findings should be interpreted cautiously given the limited number of studies included in the primary meta-analysis, the substantial heterogeneity across studies, and the observational nature of the available evidence. Future prospective, well-adjusted studies should evaluate the impact of glycemic control, diabetes-related complications, organ dysfunction, and antidiabetic treatment exposure on sepsis outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.